S0629, Observational Study of Asymptomatic Waldenstrom's Macroglobulinemia and Phase II Study of Tandem Autologous Transplant and Maintenance Treatment for Patients With Symptomatic Disease
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bortezomib; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Melphalan; Rituximab; Thalidomide
- Indications Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
Most Recent Events
- 06 Mar 2015 Biomarkers information updated
- 10 Jan 2013 Status changed from completed to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 26 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.